Roderick Tang
Principal investigator, leads MEISSA VACCINES INC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$3.1MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 1, 2019 | NIH | SBIR Phase II Development of live attenuated respiratory syncytial virus vaccines with novel thermal stable fusion protein | $340K | MEISSA VACCINES INC |
| Feb 1, 2018 | NIH | SBIR Phase II Development of live attenuated respiratory syncytial virus vaccines with novel thermal stable fusion protein | $1.3M | MEISSA VACCINES INC |
| Jan 24, 2018 | NIH | SBIR Phase II Development of live attenuated respiratory syncytial virus vaccines with novel thermal stable fusion protein | $1000K | MEISSA VACCINES INC |
| Jun 21, 2017 | NIH | SBIR Phase II Development of live attenuated respiratory syncytial virus vaccines with novel thermal stable fusion protein | $224K | MEISSA VACCINES INC |
| Feb 14, 2017 | NIH | SBIR Phase I Development of polyvalent inactivated rhinovirus vaccine | $216K | MEISSA VACCINES INC |
Peer ranks
Federal funding#579
Awards as PI#417
Patents#273
Companies
- MEISSA VACCINES INCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.